Trials / Completed
CompletedNCT00443417
A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
Dose Finding Study to Assess the Efficacy and Safety of SK-PC-B70M in Patients With Mild to Moderate Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 188 (estimated)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- All
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find optimistic dose and to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SK-PC-B70M | dosage, frequency |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2007-03-06
- Last updated
- 2009-12-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00443417. Inclusion in this directory is not an endorsement.